Log In
Print
BCIQ
Print
Print this Print this
 

Iressa, gefitinib

Also known as: ZD1839

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionEGFR kinase inhibitor
Molecular Target Epidermal growth factor receptor 1 (EGFR1) (HER1) (ErbB1)
Mechanism of ActionEpidermal growth factor (EGF) receptor kinase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today